Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH prospect

.Novo Nordisk has axed its own once-monthly double GLP-1/ GIP receptor agonist, finishing (PDF) prog...

Daiichi pays Merck $170M to form lung cancer cells T-cell engager deal

.Merck &amp Co. has promptly made back a few of the prices of its Spear Rehabs acquistion, attractin...

BioMarin standstills preclinical genetics treatment for heart disease

.After BioMarin conducted a spring well-maintained of its own pipe in April, the provider has actual...

Eisai vegetations molecular adhesive SEED with $1.5 B biobucks deal

.Huge Pharmas remain stuck to the idea of molecular adhesive degraders. The most recent business to ...

Life science credit report organization introduces with $600M

.A brand-new worldwide lifestyle science credit rating company, called Symbiotic Funding, has actual...

BMS trenches TIGIT, walking away from $200M bet on Agenus bispecific

.Bristol Myers Squibb is axing an additional huge wager coming from the Caforio time, ending a barga...

Nuvation halts BET prevention after considering phase 1 data

.After checking out at period 1 information, Nuvation Bio has actually chosen to halt work on its on...

' Scientific instinct' led FDA advisors to support Zevra's rare health condition med

.Zevra Therapies' uncommon condition medication seems to be on the road to authorization this fall a...

Pfizer takes $230M attacked after axing failed DMD genetics treatment

.Pfizer's stage 3 Duchenne muscular dystrophy (DMD) genetics treatment breakdown has blown a $230 mi...

AC Immune views 'spots' prospective in Alzheimer's medicine data

.After greater than 20 years of work on neurodegenerative ailments, Swiss biotech air conditioning I...